The role of CSE1L silencing in the regulation of proliferation and apoptosis via the AMPK/mTOR signaling pathway in chronic myeloid leukemia

References

• Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2020 update on diagnosis, therapy and monitoring. Am J Hematol. 2020;95(6):691–709.
   PubMed Web of Science ®Google Scholar
• Nguyen LT, Guo M, Naugler C, et al. Incidence of chronic myeloid leukemia in Calgary, Alberta, Canada. BMC Res Notes. 2018;11(1):780.
   PubMedGoogle Scholar
• Soverini S, Mancini M, Bavaro L, et al. Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy. Mol Cancer. 2018;17(1):49.
   PubMedGoogle Scholar
• Wang Z, Jiang L, Yan H, et al. Adverse events associated with nilotinib in chronic myeloid leukemia: mechanisms and management strategies. Expert Rev Clin Pharmacol. 2021;14(4):445–456.
   PubMed Web of Science ®Google Scholar
• Deb S, Boknäs N, Sjöström C, et al. Varying effects of tyrosine kinase inhibitors on platelet function—a need for individualized CML treatment to minimize the risk for hemostatic and thrombotic complications? Cancer Med. 2019;9(1):313–323.
   PubMed Web of Science ®Google Scholar
• Luo Y, Qu X, Kan D, et al. The microRNA-451a/chromosome segregation 1-like axis suppresses cell proliferation, migration, and invasion and induces apoptosis in nasopharyngeal carcinoma. Bioengineered. 2021;12(1):6967–6980.
   PubMed Web of Science ®Google Scholar
• Hughes TP, Ross DM. Moving treatment-free remission into mainstream clinical practice in CML. Blood. 2016;128(1):17–23.
   PubMed Web of Science ®Google Scholar
• Braun TP, Eide CA, Druker BJ. Response and resistance to BCR-ABL1-targeted therapies. Cancer Cell. 2020;37(4):530–542.
   PubMed Web of Science ®Google Scholar
• Alnabulsi A, Agouni A, Mitra S, et al. Cellular apoptosis susceptibility (chromosome segregation 1-like,CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer. J Pathol. 2012;228(4):471–481.
   PubMed Web of Science ®Google Scholar
• Liang C, Wang X, Zhang Z, et al. ACOT11 promotes cell proliferation, migration and invasion in lung adenocarcinoma. Transl Lung Cancer Res. 2020;9(5):1885–1903.
   PubMed Web of Science ®Google Scholar
• Jiang M-C. CAS (CSE1L) signaling pathway in tumor progression and its potential as a biomarker and target for targeted therapy. Tumor Biol. 2016;37(10):13077–13090.
   PubMedGoogle Scholar
• Bera TK, Bera J, Brinkmann U, et al. Cse1l is essential for early embryonic growth and development. Mol Cell Biol. 2001;21(20):7020–7024.
   PubMed Web of Science ®Google Scholar
• Behrens P, Brinkmann U, Wellmann A. CSE1L/CAS: its role in proliferation and apoptosis. Apoptosis (London). 2003;8(1):39–44.
   PubMed Web of Science ®Google Scholar
• Liao C-F, Lin S-H, Chen H-C, et al. CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cells. Mol Med. 2012;18(9):1269–1280.
   PubMed Web of Science ®Google Scholar
• Xu R, Greening DW, Rai A, et al. Highly-Purified exosomes and shed microvesicles isolated from the human colon cancer cell line LIM1863 by sequential centrifugal ultrafiltration are biochemically and functionally distinct. Methods. 2015;87:11–25.
   PubMed Web of Science ®Google Scholar
• Chang C-C, Tai C-J, Su T-C, et al. The prognostic significance of nuclear CSE1L in urinary bladder urothelial carcinomas. Ann Diagn Pathol. 2012;16(5):362–368.
   PubMed Web of Science ®Google Scholar
• Yuksel UM, Dilek G, Dogan L, et al. The relationship between CSE1L expression and axillary lymph node metastasis in breast cancer. Tumori J. 2015;101(2):194–198.
   PubMed Web of Science ®Google Scholar
• Liu W, Zhou Z, Li Y, et al. CSE1L silencing impairs tumor progression Via MET/STAT3/PD-L1 signaling in lung cancer. Am J Cancer Res. 2021;11(9):4380–4393.
   PubMed Web of Science ®Google Scholar
• Zhou S, Zhang M, Zhou C, et al. FLVCR1 predicts poor prognosis and promotes malignant phenotype in esophageal squamous cell carcinoma via upregulating CSE1L. Front Oncol. 2021;11:660955.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang X, Mao T, et al. CSE1L, as a novel prognostic marker, promotes pancreatic cancer proliferation by regulating the AKT/mTOR signaling pathway. J Cancer. 2021;12(10):2797–2806.
   PubMed Web of Science ®Google Scholar
• McGrath JP, Williamson KE, Balasubramanian S, et al. Pharmacological inhibition of the histone lysine demethylase KDM1A suppresses the growth of multiple acute myeloid leukemia subtypes. Cancer Res. 2016;76(7):1975–1988.
   PubMed Web of Science ®Google Scholar
• Legrand N, Pradier A, Poulain L, et al. AMP-Activated Protein kinase contributes to apoptosis induced by the Bcl-2 inhibitor venetoclax in acute myeloid leukemia. Cancers. 2021;13(23):5966.
   PubMed Web of Science ®Google Scholar
• Drakos E, Atsaves V, Li J, et al. Stabilization and activation of P53 downregulates mTOR signaling through AMPK in mantle cell lymphoma. Leukemia. 2009;23(4):784–790.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yang Y, Yang Y, et al. Exosomes from bone marrow microenvironment-derived mesenchymal stem cells affect CML cells growth and promote drug resistance to tyrosine kinase inhibitors. Stem Cells Int. 2020;2020:1–13.
   Web of Science ®Google Scholar
• Yan R, Fan X, Xiao Z, et al. Inhibition of DCLK1 sensitizes resistant lung adenocarcinomas to EGFR-TKI through suppression of Wnt/β-catenin activity and cancer stemness. Cancer Lett. 2022;531:83–97.
   PubMed Web of Science ®Google Scholar
• Jain P, Kantarjian H, Boddu PC, et al. Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs. Blood Adv. 2019;3(6):851–861.
   PubMed Web of Science ®Google Scholar
• Roa-Chamorro R, Torres-Quintero L, De Los Ríos CG, et al. Progressive cardiovascular disease in a patient under treatment with Nilotinib. Clín Investig Arterioscler. 2020;32(2):66–69.
   PubMed Web of Science ®Google Scholar
• Ma S, Yang D, Liu Y, et al. LncRNA BANCR promotes tumorigenesis and enhances Adriamycin resistance in colorectal cancer. Aging (Albany NY). 2018;10(8):2062–2078.
   PubMedGoogle Scholar
• Meyers RM, Bryan JG, McFarland JM, et al. Computational correction of copy number effect improves specificity of CRISPR–Cas9 essentiality screens in cancer cells. Nat Genet. 2017;49(12):1779–1784.
   PubMed Web of Science ®Google Scholar
• Ye M, Chen Y, Liu J, et al. Interfering withCSE1L /CAS inhibits tumour growth viaC3 in triple-negative breast cancer. Cell Prolif. 2022;55(5).
   Web of Science ®Google Scholar
• Nagashima S, Maruyama J, Honda K, et al. CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells. J Biol Chem. 2021;297(1):100803.
   PubMed Web of Science ®Google Scholar
• Barnaba N, LaRocque JR. Targeting cell cycle regulation Via the G2-M checkpoint for synthetic lethality in melanoma. Cell Cycle. 2021;20(11):1041–1051.
   PubMed Web of Science ®Google Scholar
• Saleh K, Khalifeh-Saleh N, Kourie HR. Acute myeloid leukemia transformed to a targetable disease. Future Oncol. 2020;16(14):961–972.
   PubMed Web of Science ®Google Scholar
• Xiao-Xing Chi, Tao Zhang, Xiao-Li Chu, et al. The regulatory effect of genistein on granulosa cell in ovary of rat with PCOS through Bcl-2 and Bax signaling pathways. J Vet Med Sci. 2018;80(8):1348–1355.
   PubMed Web of Science ®Google Scholar
• Chun Y, Kim J. AMPK–mTOR signaling and cellular adaptations in hypoxia. Int J Mol Sci. 2021;22(18):9765.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Wang X, Cao S, et al. Berberine represses human gastric cancer cell growth in vitro and in vivo by inducing cytostatic autophagy via inhibition of MAPK/mTOR/p70S6K and Akt signaling pathways. Biomed Pharmacother. 2020;128:110245.
   PubMed Web of Science ®Google Scholar
• Murugan AK. MTOR: role in cancer, metastasis and drug resistance. Semin Cancer Biol. 2019;59:92–111.
   PubMed Web of Science ®Google Scholar
• Bodur C, Karakas B, Timucin AC, et al. AMP-activated protein kinase couples 3-bromopyruvate-induced energy depletion to apoptosis via activation of FoxO3a and upregulation of proapoptotic Bcl-2 proteins. Mol Carcinog. 2016;55(11):1584–1597.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhu Z, Li C, et al. NMIIA promotes tumorigenesis and prevents chemosensitivity in colorectal cancer by activating AMPK/mTOR pathway. Exp Cell Res. 2021;398(1):112387.
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang Y, Zhang Y, et al. Periplocin induces apoptosis of pancreatic cancer cells through autophagy via the AMPK/mTOR pathway. J Oncol. 2022;2022:1–13.
   Web of Science ®Google Scholar